CA2492417C - Formulation destinee aux femmes en periode de menopause - Google Patents

Formulation destinee aux femmes en periode de menopause Download PDF

Info

Publication number
CA2492417C
CA2492417C CA002492417A CA2492417A CA2492417C CA 2492417 C CA2492417 C CA 2492417C CA 002492417 A CA002492417 A CA 002492417A CA 2492417 A CA2492417 A CA 2492417A CA 2492417 C CA2492417 C CA 2492417C
Authority
CA
Canada
Prior art keywords
fatty acid
derivative
acid compound
amount
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002492417A
Other languages
English (en)
Other versions
CA2492417A1 (fr
Inventor
R. Saul Levinson
Marc S. Hermelin
Mitchell I. Kirschner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/409,059 external-priority patent/US6479545B1/en
Application filed by Drugtech Corp filed Critical Drugtech Corp
Priority to CA002645397A priority Critical patent/CA2645397A1/fr
Publication of CA2492417A1 publication Critical patent/CA2492417A1/fr
Application granted granted Critical
Publication of CA2492417C publication Critical patent/CA2492417C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002492417A 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause Expired - Fee Related CA2492417C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002645397A CA2645397A1 (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/409,059 1999-09-30
US09/409,059 US6479545B1 (en) 1999-09-30 1999-09-30 Formulation for menopausal women
CA002385854A CA2385854C (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002385854A Division CA2385854C (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002645397A Division CA2645397A1 (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Publications (2)

Publication Number Publication Date
CA2492417A1 CA2492417A1 (fr) 2001-04-12
CA2492417C true CA2492417C (fr) 2008-12-02

Family

ID=34378561

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002492417A Expired - Fee Related CA2492417C (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Country Status (1)

Country Link
CA (1) CA2492417C (fr)

Also Published As

Publication number Publication date
CA2492417A1 (fr) 2001-04-12

Similar Documents

Publication Publication Date Title
CA2385854C (fr) Formulation destinee aux femmes en periode de menopause
US6258846B1 (en) Nutritional supplements
US6352713B1 (en) Nutritional composition
US20030216351A1 (en) Nutritional supplements
WO2000066133A1 (fr) Complements alimentaires
SK12398A3 (en) Two-stage preparation
JP2005520816A (ja) 経口または直腸投与用組成物
CA2492417C (fr) Formulation destinee aux femmes en periode de menopause
AU2005200907B2 (en) Formulation for menopausal women
US9308261B2 (en) Compositions and methods for treating varicose veins

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed